1. VEGF Promoter Haplotype and Amyotrophic Lateral Sclerosis (ALS).
- Author
-
TERRY, PAUL D., KAMEL, FREYA, UMBACH, DAVID M., LEHMAN, TERESA A., HU, HOWARD, SANDLER, DALE P., and TAYLOR, JACK A.
- Subjects
AMYOTROPHIC lateral sclerosis ,NEUROMUSCULAR diseases ,MOTOR neuron diseases ,NEUROGENETICS ,NEUROSCIENCES - Abstract
Vascular endothelial growth factor(VEGF)is a cytokine essential for angiogenesis. A recent study found that haplotypes, determined by three SNPs(  -  2,578C/A,  -  1,154 G/A, and  -  634G/C)in theVEGFupstream promoter/leader sequence, were associated with risk of amyotrophic lateral sclerosis(ALS). We used samples and data from a case-control study to examine the relation of ALS toVEGFhaplotype. Genotypes at each of the three polymorphic sites were determined using allele-specific primer extension reactions followed by MALDI-TOF. We found a 3-fold increased risk among individuals homozygous for the AAG or AGG haplotypes(95%CI  =  0.7  -  13.4), consistent with the findings of the previous study. Given the wide confidence interval, our findings should be interpreted cautiously. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF